semaglutide and naion A new study suggests patients taking — the active ingredient in Ozempic Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Smaller NAION Risk with Semaglutide

While many resources exist, the 7-day plan outlined in this article is designed to be comprehensive

They work through entirely different mechanisms

Medical supervision allows us to monitor weight trends, evaluate body composition, adjust nutrition recommendations, and make dose changes when appropriate

(Patient specific dosing.) Ongoing maintenance programs

Both are incretin-based therapies that affect appetite and insulin, and combining them could significantly increase your risk of side effects such as: Severe nausea or vomiting Pancreatitis Gastrointestinal distress Low blood sugar (especially if diabetic) In addition to the physical risks, combining these two would also confuse your treatment plan, making it harder to track which drug is delivering results or causing issues